Cargando…
COVID-19 and angiotensin-converting enzyme inhibitors from plant origin
| Autores principales: | , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Shanghai Yueyang Hospital Affiliated to Shanghai University of Traditional Chinese Medicine. Published by Elsevier B.V.
2022
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9192126/ https://www.ncbi.nlm.nih.gov/pubmed/35750624 http://dx.doi.org/10.1016/j.joim.2022.06.005 |
| _version_ | 1784726168601100288 |
|---|---|
| author | Gharebaghi, Reza Heidary, Fatemeh |
| author_facet | Gharebaghi, Reza Heidary, Fatemeh |
| author_sort | Gharebaghi, Reza |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-9192126 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2022 |
| publisher | Shanghai Yueyang Hospital Affiliated to Shanghai University of Traditional Chinese Medicine. Published by Elsevier B.V. |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-91921262022-06-14 COVID-19 and angiotensin-converting enzyme inhibitors from plant origin Gharebaghi, Reza Heidary, Fatemeh J Integr Med Letter to the Editor Shanghai Yueyang Hospital Affiliated to Shanghai University of Traditional Chinese Medicine. Published by Elsevier B.V. 2022-09 2022-06-14 /pmc/articles/PMC9192126/ /pubmed/35750624 http://dx.doi.org/10.1016/j.joim.2022.06.005 Text en © 2022 Shanghai Yueyang Hospital Affiliated to Shanghai University of Traditional Chinese Medicine. Published by Elsevier B.V. All rights reserved. Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active. |
| spellingShingle | Letter to the Editor Gharebaghi, Reza Heidary, Fatemeh COVID-19 and angiotensin-converting enzyme inhibitors from plant origin |
| title | COVID-19 and angiotensin-converting enzyme inhibitors from plant origin |
| title_full | COVID-19 and angiotensin-converting enzyme inhibitors from plant origin |
| title_fullStr | COVID-19 and angiotensin-converting enzyme inhibitors from plant origin |
| title_full_unstemmed | COVID-19 and angiotensin-converting enzyme inhibitors from plant origin |
| title_short | COVID-19 and angiotensin-converting enzyme inhibitors from plant origin |
| title_sort | covid-19 and angiotensin-converting enzyme inhibitors from plant origin |
| topic | Letter to the Editor |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9192126/ https://www.ncbi.nlm.nih.gov/pubmed/35750624 http://dx.doi.org/10.1016/j.joim.2022.06.005 |
| work_keys_str_mv | AT gharebaghireza covid19andangiotensinconvertingenzymeinhibitorsfromplantorigin AT heidaryfatemeh covid19andangiotensinconvertingenzymeinhibitorsfromplantorigin |